The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study - sprookjes - yvandenbroek - TriplyDB

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

http://www.wikidata.org/entity/Q24530092

about

Cystic Fibrosis: Lessons from the Sweat Gland Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion.Evaluating candidate agents of selective pressure for cystic fibrosis CFTR in cystic fibrosis and cholera: from membrane transport to clinical practice Pathophysiology of gene-targeted mouse models for cystic fibrosis Lung infections associated with cystic fibrosis.Salmonella typhi uses CFTR to enter intestinal epithelial cells.Electrolyte transport in the mammalian colon: mechanisms and implications for disease.Low abundance of sweat duct Cl- channel CFTR in both healthy and cystic fibrosis athletes with exceptionally salty sweat during exercise.A mouse model for the delta F508 allele of cystic fibrosis.Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium.Evidence for intestinal chloride secretion.delta F508 in cystic fibrosis: willing but not able.Complementation of null CF mice with a human CFTR YAC transgene.Formal analysis of electrogenic sodium, potassium, chloride and bicarbonate transport in mouse colon epithelium.Rectal potential difference and the functional expression of CFTR in the gastrointestinal epithelia in cystic fibrosis mouse models.CFTR genotype-related body water and electrolyte balance during a marathon.Generation and characterization of a delta F508 cystic fibrosis mouse model.ITD in Ashkenazi Jews--genetic drift or selection?

P2860

Q22306467-6E9CF2FC-C72E-4526-9A95-290D96294EA1 Q24538931-3E1C1E80-A713-45BF-8ED3-B4189B401FFB Q24654240-C24677FC-EBC5-477B-AE68-485AA20C87DA Q28251742-1AA51CB0-8BD6-48A7-BDF5-229C0EA2BA61 Q28295602-913DCEF7-F460-4E3B-AFB9-7960C80C822E Q30080000-A98F529F-6906-4EC9-99D4-B6E503705B6E Q34066552-9A8116A4-C268-4054-8948-FCF9C3CB3318 Q34482550-0280944D-5F79-45B1-B70E-8F59B03FC8FF Q34720109-2B3A61D8-E01E-4746-94E4-3255C4BA333E Q35765143-8B4AE034-3738-449D-A4BC-B59C52185563 Q37061658-20E23461-4446-4DC1-BF14-C1F9E2284A75 Q37710221-A58AEABE-79FF-4571-BB51-C4A2586F8AB7 Q41458212-E080A8F4-A26C-41D0-9814-C1981C1DB0F9 Q42183922-94053524-BA35-4E55-BDAB-E121A9643CC0 Q43188376-4FB5D30E-8200-456C-B8B5-E2F692F311A8 Q46878723-54F60201-2B47-4202-A514-39D1F4FEF137 Q48145566-D13EF4C6-FEC7-4E9A-ABDC-D4239FA5ECC8 Q52207066-0CDD14D5-436B-46D1-B418-9B7C00AE3381 Q53639429-676D7C20-84A4-4FBB-860D-7A82ECD29029

P2860

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

http://www.wikidata.org/entity/Q24530092

description

1995 nî lūn-bûn

@nan

1995 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@ast

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@en

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@en-gb

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@nl

type

label

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@ast

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@en

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@en-gb

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@nl

prefLabel

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@ast

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@en

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@en-gb

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@nl

P1433

Q24530092-CB2FD11C-A4F6-4538-BEDF-B138C49C3311

P1476

Q24530092-AE187DE0-E89A-49DA-B072-B8308FF49D65

P2093

Q24530092-3B2D48F2-A89C-4529-9788-9F7F66127047

Q24530092-4C8B0FC5-4107-4625-8C58-4BFE3D47A51F

Q24530092-50DB21FF-090F-4883-97BE-5960E49B3735

Q24530092-7F97D147-9A82-4DF0-8FEE-97E2E92DF902

Q24530092-A4459524-2B6D-4DFB-91F1-EA74AC1EE627

P2860

Q24530092-1809DAAB-0F2D-4821-8052-2E0E17997A65

Q24530092-426A7B9C-8D8E-4B84-87EC-E961B66EACF9

Q24530092-4283763E-8113-4ECF-8153-E465CA1767E1

Q24530092-52E74C0B-8222-473B-A063-55F3CC40328E

Q24530092-6E3267F8-EB3D-4C6E-ACBE-49403718F834

Q24530092-9A1ED4B3-D352-4629-B12E-305F12EE47B9

Q24530092-A2807B7E-9710-4A72-BEB6-E2FA23545AE5

Q24530092-A5E7DE5A-7087-43B5-B38F-93794352381C

Q24530092-B0C4C26F-AB60-481C-9C36-1687333802C6

Q24530092-CD998C96-5CA0-4D4C-A33F-9E6829097271

P304

Q24530092-9FE89A7C-42F0-4A68-8B9A-33E0D0B83D8F

P31

Q24530092-C885CC1F-502B-4568-A7AA-7D7B7689831D

P356

Q24530092-54E1F002-8E32-4522-AEC2-4CAF8591BBA6

P407

Q24530092-F26A0651-22F9-4EF8-AF24-4B1F1B8C8A3F

P478

Q24530092-67B7091E-16D2-4E45-BD0E-E738014F6F66

P577

Q24530092-D8213EA5-2FAF-42A8-B654-8FA4F8F3C8B4

P5875

Q24530092-2E80E1BD-7517-4990-9968-E71812B0BA03

P698

Q24530092-725B240D-20D1-4C41-A163-F98AC87F857B

P921

Q24530092-F73877CB-F4EC-4E58-957B-CA636A3BB6D5

P932

Q24530092-CF923BA5-D263-45AD-AA43-C17F2E7A3645

P356

JPHYSIOL.1995.SP020531

P1433

The Journal of Physiology

P1476

The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study

@en

P2093

A W Cuthbert

http://www.w3.org/2001/XMLSchema#string

J Halstead

http://www.w3.org/2001/XMLSchema#string

M J Evans

http://www.w3.org/2001/XMLSchema#string

R Ratcliff

http://www.w3.org/2001/XMLSchema#string

W H Colledge

http://www.w3.org/2001/XMLSchema#string

P2860

Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model

Cystic fibrosis: molecular biology and therapeutic implications.

Activation of intestinal CFTR Cl- channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase.

Gates of Janus: cystic fibrosis and diarrhea.

Human genetics. What is good about cystic fibrosis?

Toxigenic diarrheas, congenital diarrheas, and cystic fibrosis: disorders of intestinal ion transport.

Diffusion of drugs through stationary water layers as the rate limiting process in their action at membrane receptors.

Failure to induce secretion in jejunal biopsies from children with cystic fibrosis.

Chloride secretion in response to guanylin in colonic epithelial from normal and transgenic cystic fibrosis mice.

Abnormal epithelial transport in cystic fibrosis jejunum.

P304

449-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1113/JPHYSIOL.1995.SP020531

http://www.w3.org/2001/XMLSchema#string

P407

P478

482 ( Pt 2)

http://www.w3.org/2001/XMLSchema#string

P577

1995-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15484021

http://www.w3.org/2001/XMLSchema#string

P698

7714835

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

1157742

http://www.w3.org/2001/XMLSchema#string